Burris, K. D., Molski, T. F., Xu, C. et al: Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J. Pharmacol. Exp. Ther., 302: 381-389, 2002.
Delay, J., Deniker, P., Harl, J. M.: Utilization on therapeutique psychiatrique d’une phenothiazine d’action centrale elective. Ann. Med. Psychol.(Paris), 110: 112-117, 1952.
DeLeon, A., Patel, N. C., Crismon, M. L.: Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability. Clin. Ther., 26(5): 649-666, 2004.
Farde, L., Wiesel, F. A., Halldin, C. et al.: Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry, 45(1): 71-76, 1988.